Trending In The News
Scientific American: Neuroscientist Michael Heneka knows that radical ideas require convincing data. In 2010, very few colleagues shared his belief that the brain’s immune system has a crucial role in dementia. So in May of that year, when a batch of new results provided the strongest evidence he had yet seen for his theory, he wanted to be excited, but instead felt nervous. READ MORE
Forbes: “Nobody’s talking about this story,” Max Tokarsky said. Not exactly true, as the founder and CEO of InvestAcure is telling anyone who will listen. A former non-profit executive-turned-evangelist for the Impact Investment and Public Benefit Corporation model, Tokarsky is slated to present the keynote address at the Alzheimer's-2018 International Conference in Rome, Italy May 8. He wants to talk about funding a cure for Alzheimer’s disease. But he’s not talking about just asking major corporations or the government or even Big Pharma for help. Tokarsky wants everyone to pitch in. And he’s figured out a way we can. READ MORE
Washington Post: My story began in the 1950s, when an Indian immigrant journeyed to the United States to chase the dream this country promised — opportunity. This brave man, my father, had visions of earning a PhD and raising a family. He wanted to affect American society through his work, the way he led his life and the values he instilled in his children. READ MORE
San Diego Union Tribune: Alzheimer’s disease causes brain cells to die, so the brain works less well over time. This changes how a person acts. This article prepared by the National Institute on Aging has suggestions that may help you understand and cope with changes in personality and behavior in a person with Alzheimer’s disease. READ MORE
NBC News: Government and other scientists are proposing a new way to define Alzheimer’s disease — basing it on biological signs, such as brain changes, rather than memory loss and other symptoms of dementia that are used today. The move is aimed at improving research, by using more objective criteria like brain scans to pick patients for studies and enroll them sooner in the course of their illness, when treatments may have more chance to help. READ MORE
